Nebulizers Market Key Findings, Future Insights, Market Revenue and Threat Forecast by 2027

[Priya Raut]

Scope of the Report

Market Research Future (MRFR) expects the nebulizers market to attain a valuation of USD 1,629.7 Million by the year 2027. It is also presumed that the market size will continue to soar at a rate of 7.32% between 2020 and 2027.

Top Boosters and Key Barriers

The COVID-19 outbreak has interestingly been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have pushed the demand for albuterol inhalers across hospitals for treating suspected patients suffering from respiratory issues. COVID-19 is a common facilitator of asthma or respiratory exacerbations, with the geriatric population deemed to be more susceptible to these health conditions. This demography is also highly prone to several respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as sleep apnea. In a nutshell, the burgeoning elderly population should foster the demand for nebulizers market in the upcoming years.

Drug wastage is one of the biggest challenges faced by the healthcare sector following device usage. Sensing the opportunity, several companies are coming up with highly innovative nebulizers such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut down drug wastage and enhance the efficiency of drug delivery. Such nebulizers help elevate the output rate while reducing the entire administration period. Besides, the heightened demand for healthcare devices that can be used at home and the surging consumption of cigarettes, alcohol and tobacco that cause respiratory disorders should also enhance the market size in the years to come.

Companies Profiled

Braun Melsungen AG (Germany), Invacare Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US), Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the prominent firms in the global market.

Segmental Status

The nebulizers industry has been dissected with respect to type, usage, portability along with end user.

The nebulizer types that are available in the global market are jet, ultrasonic as well as mesh. The types of mesh nebulizers include passive and active. From the main types of nebulizers, the jet nebulizers types should procure the top position over the following years since they are far more cost-effective compared to other types in the market and should therefore, note higher demand.

Usage-wise, the major segments can be reusable and disposable. Out of these, the leading spot has been secured by disposable nebulizers, as these witness significant demand given the provision of reduced infection rate as well as wastage.

Portable and tabletop are identified as the main segments, as per portability. The portable nebulizers market has been progressing at the fastest pace, thanks to its convenient coupled with ease of use.

Home care, along with hospitals & clinics are the industry end-users covered in the MRFR study. In light of the expanding patient base, hospitals and clinics have emerged as the leading segment in the market. But, it is likely that the homecare segment will achieve the fastest growth rate in the years ahead.

Regional Status

Europe/EU, the Americas, Asia Pacific/APAC and Middle East and Africa/MEA are the key regions across which the nebulizers market is expected to note growth over the review period.

The American market has emerged the clear winner out of the regions, on account of the alarming growth in respiratory disorders and the favorable reimbursement schemes available in the region. The region’s performance will be further bolstered by the fact that consumers here follow a fast-moving lifestyle and therefore, opt for portable devices that are compact and have multiple advanced features. This scenario is also favored by the escalating cases of asthma and a number of airway diseases in the region.

The European market stands second and is expected to attain higher growth in the coming years, in view of the fast-expanding elderly patient base affected by several respiratory diseases. Frequent technological advances and the emergence of new and more sophisticated nebulizers in the market should be favorable as well.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.